The present invention relates to the use of bi-cyclic pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to processes for pre
-
Page/Page column 44
(2010/10/20)
More Articles about upstream products of 773140-09-3